Watchdog bans import of Daewoong injections
Print Edition
China’s drug watchdog has banned imports of a set of antibiotic injections manufactured by a South Korean pharmaceutical company due to its refusal to accept spot checks.
According to a statement issued by the China Food and Drug Administration yesterday, it has ordered all ports to stop importing cefmetazole produced by the Daewoong Pharmaceutical Co Ltd.
The statement quoted an unnamed CFDA official as saying that the administration had planned to inspect the production facilities of some imported goods, including Daewoong Pharmaceutical’s cefmetazole, in order to strengthen management of such products, a policy which is in line with the CFDA’s annual arrangements.
However, Daewoong Pharmaceutical did not allow checks despite a prearranged schedule.
The CFDA therefore decided to ban cefmetazole until it can make sure the product meets Good Manufacturing Practice standards after conducting spot checks, the official said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
